Page results
-
This page has been written by the Department of Neurosurgery at the National Hospital for Neurology and Neurosurgery to provide general information about the care of your surgical wound. Your ward nurse and neurosurgeon will discuss any needs that you have in detail.
-
This information is intended for patients who are receiving GnRH-a injections as part of their treatment at UCLH.
-
This information is for children and young people with type 1 diabetes using a hybrid closed loop (HCL).
-
Dr Sen is a triple accredited consultant physician in stroke, geriatric and general internal medicine
-
At UCLH we recognise how cancer and its treatment can affect the lives of patients and those close to them. We provide support, information and advice.
-
Her Majesty The Queen’s state funeral will be held on Monday 19 September, and will be a national bank holiday.
-
This page explains what a cervical cerclage involves and the risks and benefits of the procedure.
-
Mouth cancer is where a tumour develops on the surface of the tongue, lips, gums or jaws.
-
Thyroid cancer is a type of cancer that affects the thyroid gland, a small gland at the base of the neck.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
File results
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0007 - Outpatient activity for 2022